EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention

Sheila H Ridner iD, Mary S Dietrich, John Boyages iD, Louise Koelmeyer, Elisabeth Elder, T Michael Hughes iD, James French, Nicholas Ngui, Jeremy Hsu, Vandana G Abramson, Andrew Moore, Chirag Shah

Lymphatic Research and Biology · 01.12.2022 · 20 (6) · 618-628

DOI: 10.1089/lrb.2021.0084 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Lymphatic Research and Biology, online erschienen am 15.12.2022. Verfasst von Sheila H Ridner und 11 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University School of Nursing, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Breast Cancer Lymphedema, Breast Neoplasms, Lymphedema. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study compared rates of progression to chronic breast cancer-related lymphedema (defined as ≥ 10% arm volume change from baseline requiring complex decongestive physiotherapy [CDP]) following an intervention for subclinical lymphedema (S-BCRL) triggered by bioimpedance spectroscopy (BIS) or by tape measurement (TM). Methods and Results: This stratified, randomized, international trial enrolled new breast cancer patients undergoing: mastectomy/partial mastectomy, axillary treatment (dissection, sentinel lymph node biopsy [SLNB] >6 nodes or radiation), radiation therapy (chest wall/breast, supraclavicular fossa), or taxane-based chemotherapy. Following postsurgery eligibility reassessment, centralized, 1:1 randomization to prospective surveillance by BIS or TM occurred. S-BCRL detection triggered a 4-week, 12-hour per day, compression sleeve, and gauntlet intervention. The primary outcome ( n = 209), rates of postintervention progression to CDP, was assessed over 3 years. Between June 24, 2014 and September 11, 2018, 1200 patients were enrolled, 963 randomized (BIS n = 482; TM n = 481) and 879 analyzed (BIS n = 442; TM n = 437). Median follow-up was 32.9 months (interquartile range = 22, 35). BIS patients triggered an intervention at a lower rate than TM patients (20.1%, n = 89 vs. 27.5%, n = 120, p = 0.011). Median months to trigger were longer with BIS than TM (9.7; 95% confidence interval [CI], 8.2–12.6 vs. 3.9; 95% CI, 2.8–4.5, p = 0.001). Overall, 14.4% ( n = 30) progressed post-intervention, with reduced likelihood for BIS patients than TM patients (7.9%, n = 7 vs. 19.2%, n = 23; relative risk = 0.41; 95% CI, 0.13–0.81; absolute reduction 11.3%; 95% CI, 2.3–20.3; p = 0.016).

Conclusions

Compared to TM, BIS provides a more precise identification of patients likely to benefit from an early compression intervention. Clinical Trial Registration number: NCT02167659.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast Cancer LymphedemaBreast NeoplasmsLymphedemaFemaleHumansAxillaLymph Node ExcisionMastectomyProspective StudiesSentinel Lymph Node BiopsySpectrum Analysis

Stichwörter der Autor:innen

bioimpedance spectroscopybreast cancerlymphedemapreventiontape measure

Autor:innen und Institutionen

  • Vanderbilt University School of Nursing, Nashville, Tennessee, USA.
  • Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Australian Lymphoedema Education, Research, and Treatment Program, Macquarie University, Macquarie Park, Australia.
  • Department of Clinical Medicine, Macquarie University, Macquarie Park, Australia.
  • Medicine, Health & Human Sciences, ICON Cancer Center, Wahroonga, Australia.
  • Westmead Breast Cancer Institute, Westmead Hospital, Westmead, Australia.

ORCID-Profile: Sheila H Ridner, John Boyages, T Michael Hughes

Zitieren

APA

Ridner, S. H., Dietrich, M. S., Boyages, J., Koelmeyer, L., Elder, E., Hughes, T. M., French, J., Ngui, N., Hsu, J., Abramson, V. G., Moore, A., & Shah, C. (2022). A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention. Lymphatic Research and Biology, 20(6), 618-628. https://doi.org/10.1089/lrb.2021.0084

Vancouver

Ridner SH, Dietrich MS, Boyages J, Koelmeyer L, Elder E, Hughes TM, et al. A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention. Lymphatic Research and Biology. 2022;20(6):618-628. doi:10.1089/lrb.2021.0084

BibTeX
@article{Ridner2022,
  author = {Ridner, Sheila H and Dietrich, Mary S and Boyages, John and Koelmeyer, Louise and Elder, Elisabeth and Hughes, T Michael and French, James and Ngui, Nicholas and Hsu, Jeremy and Abramson, Vandana G and Moore, Andrew and Shah, Chirag},
  title = {A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention},
  journal = {Lymphatic Research and Biology},
  year = {2022},
  volume = {20},
  number = {6},
  pages = {618--628},
  doi = {10.1089/lrb.2021.0084}
}
Kostenlos starten →